膀胱癌膀胱切除术前后的直接和间接成本评估：一项真实世界证据研究

数据集获取（Figshare）

• 源站标题：An assessment of the direct and indirect costs of bladder cancer preceding and following a cystectomy: a real-world evidence study
• DOI：10.6084/m9.figshare.26336859.v1
• 发布日期：2024-07-19
• 文件数：2 个
• 文件总体积：127.60 KB
• 源站页面：https://tandf.figshare.com/articles/dataset/An_assessment_of_the_direct_and_indirect_costs_of_bladder_cancer_preceding_and_following_a_cystectomy_a_real-world_evidence_study/26336859

命令行下载

curl -L -o "ijme_a_2382639_sm5689.docx" "https://ndownloader.figshare.com/files/47804331"
curl -L -o "ijme_a_2382639_sm5684.docx" "https://ndownloader.figshare.com/files/47804334"

文件清单

• ijme_a_2382639_sm5689.docx（58.41 KB）
• ijme_a_2382639_sm5684.docx（69.19 KB）

文件总体积 127.60 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

To estimate the direct and indirect costs of bladder cancer prior to and following cystectomy in a U.S. sample of patients.
This retrospective, observational analysis of de-identified patients with bladder cancer utilized the MarketScan Commercial Claims & Encounters and Health & Productivity Management databases. Adult patients with bladder cancer plus ≥ 1 claim for partial or radical cystectomy between 1 October 2015 and 31 December 2020 (date of the cystectomy = index date) and who were continuously enrolled for 6 months pre- (baseline) and post-index (follow-up) were included in the sample. All-cause total healthcare costs and indirect costs associated with short-term and long-term disability (STD and LTD) employer claims were assessed during each of the 6-month baseline and follow-up periods.
The study included N = 142 patients; mean age 56 ± 6 years, 76% (male), and 42% had a baseline Deyo-Charlson Comorbidity Index ≥ 2. Baseline mean total all-cause direct healthcare costs were $51,473 ± $48,560 (median: $36,202), and $99,524 ± 86,839 (median: $75,444) during follow-up. At baseline, 32% of patients had ≥ 1 STD claim, equating to a mean 134 ± 303 h lost and $2,353 ± $6,445 in total payments per patient. Follow up STD claims increased 23.4% equating to a mean 218 ± 324 h lost and $3,679 ± $7,795 per patient. Patient LTD claims increased from baseline to follow-up (1–3%), with post-cystectomy LTD claims resulting in 574 ± 490 h lost, and $1,636 ± $1,429 in total payments. Over 85% of the population had a cystectomy related complication, the most common were genitourinary-related (47.9%) and infection/sepsis (33.1%).
Cystectomy was associated with complications and decreased work productivity post-surgery. Findings may aid to inform decisions regarding cystectomy vs. bladder preservation approaches, and underscores an ongoing need to further develop bladder preservation therapies within the bladder cancer treatment landscape.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.26336859.v1（source: https://tandf.figshare.com/articles/dataset/An_assessment_of_the_direct_and_indirect_costs_of_bladder_cancer_preceding_and_following_a_cystectomy_a_real-world_evidence_study/26336859）。